Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Capability of Brain Mast Cells for Therapeutic use in Immune Response to Bacterial and Viral Infections

Glenn Govender*
Catalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, South Africa
*Corresponding Author: Glenn Govender, Catalysis and Peptide Research Unit, University of KwaZulu-Natal, Durban, South Africa, Email: glenn154@gmail.com

Received Date: Jul 01, 2024 / Published Date: Jul 29, 2024

Citation: Glenn G (2024) Capability of Brain Mast Cells for Therapeutic use in Immune Response to Bacterial and Viral Infections. Otolaryngol (Sunnyvale) 14: 585.

Copyright: © 2024 Glenn G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 
To read the full article Peer-reviewed Article PDF image

Abstract

Mast cells, traditionally known for their role in allergic responses, are increasingly recognized for their involvement in immune modulation and host defense beyond allergic reactions. This review explores the emerging understanding of brain mast cells (BMCs) and their potential therapeutic applications in combating bacterial and viral infections. BMCs, located in the central nervous system (CNS), possess unique immunological properties that influence neuroinflammation and host defense mechanisms. Recent studies indicate BMCs' ability to respond to pathogens directly and modulate immune responses in infectious diseases. Understanding BMCs' capabilities and harnessing their therapeutic potential could lead to novel strategies for treating infections affecting the CNS and beyond.

Top